Omeprazole Stada

Omeprazole, the active ingredient in Omeprazole Stada, is a proton‑pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazole Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Stada is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder.

Adverse reactions to Omeprazole Stada may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Stevens‑Johnson syndrome: severe skin reaction. - Hepatotoxicity: liver enzyme elevation. - Hypomagnesemia: low magnesium levels. - Fracture risk: increased risk of hip, wrist or spine fractures with long‑term use.

When prescribing Omeprazole Stada, consider the following safety measures: - Assess renal and hepatic function: adjust use if impairment. - Review medication history: avoid concomitant use with drugs that require acidic gastric pH for absorption.\n- Monitor for long‑term therapy: consider periodic assessment of magnesium and vitamin B12. - Pregnancy and lactation: use only if clearly needed. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Omeprazole Stada can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: decreased antiplatelet effect. - Atazanavir: reduced absorption due to increased gastric pH. - Ketoconazole: markedly reduced absorption.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: reduced serum levels. - Digoxin: possible increase in serum concentration. - Methotrexate: enhanced toxicity at high doses.